HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 35 filers reported holding HORIZON PHARMA INVT LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,012,000 | -90.8% | 1,040,000 | -94.5% | 0.00% | -92.5% |
| Q1 2020 | $21,945,000 | +6.3% | 19,000,000 | +22.0% | 0.04% | +37.9% |
| Q4 2019 | $20,653,000 | +330.5% | 15,580,000 | +210.5% | 0.03% | +190.0% |
| Q4 2016 | $4,797,000 | +9.7% | 5,017,000 | +11.5% | 0.01% | +11.1% |
| Q3 2016 | $4,373,000 | -31.4% | 4,500,000 | -35.7% | 0.01% | -30.8% |
| Q2 2016 | $6,378,000 | -35.0% | 7,000,000 | -38.9% | 0.01% | -38.1% |
| Q1 2016 | $9,811,000 | – | 11,450,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|